TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30621733

Group type: EXPERIMENTAL
Intervention: Right-lateral position
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Left-lateral position
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 135

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 135
Study: 27912104

Group type: EXPERIMENTAL
Intervention: Structured practice group (SPG) with skill progression
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unstructured practice group (UPG) without skill progression
Number of subjects: 20
Study: 24687247

Group type: EXPERIMENTAL
Intervention: M-Essential Oils (M-EO)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 0.2 % Chlorhexidine (M-0.2 % chlorhexidine)
Number of subjects: 15

Group type: COMPARATOR
Intervention: M-WATER
Number of subjects: 15
Study: 23880971

Group type: EXPERIMENTAL
Intervention: OPN-305
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 22084333

Group type: EXPERIMENTAL
Intervention: 90-Hz WBV therapy
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: 30-Hz WBV therapy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (no WBV therapy)
Number of subjects: 202
Study: 19501587

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 17016233

Group type: EXPERIMENTAL
Intervention: CHEK2 SNP rs2017309 A allele presence
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy and radiotherapy
Number of subjects: 213
Study: 15799931

Group type: EXPERIMENTAL
Intervention: Cypher drug-eluting stents
Number of subjects: 200

Group type: COMPARATOR
Intervention: BITA grafting
Number of subjects: 200
Study: 11194409

Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography (PET) study examining brain activity during verbal discrimination learning
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Multi-trial verbal discrimination learning task
Number of subjects: 16
Study: 9489439

Group type: EXPERIMENTAL
Intervention: Chemiluminescence (CL) response of PMNLs to chemotactic peptide FMLP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (healthy blood donors)
Number of subjects: 48
Study: 8397489

Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg once daily, administered either as a single dose or repeated for 2 to 6 days.
Number of subjects: 0
Study: 3491794

Group type: EXPERIMENTAL
Intervention: 100 mg fluproquazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 500 mg paracetamol
Number of subjects: 0
Study: 29492612

Group type: EXPERIMENTAL
Intervention: Oral TXA (two doses of 20 mg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intravenous TXA (two doses of 15 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral TXA
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intravenous TXA
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 27567675

Group type: EXPERIMENTAL
Intervention: Unpreserved latanoprost eye drops (UNL)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Preserved latanoprost eye drops (LBAK)
Number of subjects: 183
Study: 25379438

Group type: EXPERIMENTAL
Intervention: Milnacipran (MLN)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 22088201

Group type: EXPERIMENTAL
Intervention: Painless STEMI
Number of subjects: 763

Group type: COMPARATOR
Intervention: Painful STEMI
Number of subjects: 763
Study: 20733096

Group type: EXPERIMENTAL
Intervention: Atrasentan (10 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 18275882

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors
Number of subjects: 4

Group type: COMPARATOR
Intervention: Clomiphene Citrate (CC)
Number of subjects: 4
Study: 17187087

Group type: EXPERIMENTAL
Intervention: Physiotherapeutic follow-up (Group B)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Observational follow-up (Group A)
Number of subjects: 17
Study: 11979505

Group type: EXPERIMENTAL
Intervention: calcium (500 mg day(‐1)) + calcitonin (nasal spray 100 U day(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: calcium only
Number of subjects: 30
Study: 10228617

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 7867354

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 60
Study: 1789813

Group type: EXPERIMENTAL
Intervention: Simvastatin (S)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Simvastatin (S) + Cholestyramine (C)
Number of subjects: 48
Study: 7149969

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 25 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 50 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 100 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 250 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (general)
Number of subjects: 15
Study: 29802136

Group type: EXPERIMENTAL
Intervention: Oropharyngeal suction
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oropharyngeal swab
Number of subjects: 24
Study: 30375324

Group type: EXPERIMENTAL
Intervention: Abdominal massage plus advice
Number of subjects: 189

Group type: COMPARATOR
Intervention: Advice only
Number of subjects: 189
Study: 27525365

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 136
Study: 24528648

Group type: EXPERIMENTAL
Intervention: Leukodepleted RBC transfusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-leukodepleted RBC transfusion
Number of subjects: 20
Study: 21703724

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) at a frequency of 6 Hz for 5 consecutive days, daily series of 5 periods of 1 minute
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 34
Study: 20363809

Group type: EXPERIMENTAL
Intervention: Participatory workplace intervention
Number of subjects: 145

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 145
Study: 18053384

Group type: EXPERIMENTAL
Intervention: Excision of endometriosis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 100
Study: 16075779

Group type: COMPARATOR
Intervention: Fixed Repetition (FR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Periodised (PER)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Control (C)
Number of subjects: 60
Study: 12118758

Group type: EXPERIMENTAL
Intervention: Prophylactic minitracheostomy insertion with regular aspiration
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard postoperative respiratory therapy
Number of subjects: 102
Study: 9752429

Group type: EXPERIMENTAL
Intervention: Laparoscopic totally preperitoneal (TPP) approach
Number of subjects: 461

Group type: COMPARATOR
Intervention: Shouldice procedure
Number of subjects: 461

Group type: COMPARATOR
Intervention: Stoppa procedure
Number of subjects: 461
Study: 7915237

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epanolol
Number of subjects: 20
Study: 3135167

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2g
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cefotaxime 2g
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study: 28755409

Group type: EXPERIMENTAL
Intervention: REGN1193 (0.05 to 0.6 mg/kg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: REGN1193 (0.6 mg/kg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: REGN1193 (all doses)
Number of subjects: 56
Study: 27154359

Group type: EXPERIMENTAL
Intervention: DHA (800mg/day)
Number of subjects: 0
Study: 25570401

Group type: EXPERIMENTAL
Intervention: User-driven treadmill control (active walking)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal treadmill (passive walking)
Number of subjects: 9
Study: 22850268

Group type: EXPERIMENTAL
Intervention: Sertindole (mean dose=17 mg/day)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Olanzapine (mean dose=16 mg/day)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Sertindole and Olanzapine
Number of subjects: 389
Study: 20470069

Group type: EXPERIMENTAL
Intervention: Training with a canine abdominal model (n = 15)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Experienced group (n = 8)
Number of subjects: 33
Study: 18496508

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 860

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 860
Study: 15717192

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 607

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Quality of life questionnaire
Number of subjects: 607
Study: 15223075

Group type: EXPERIMENTAL
Intervention: High-flavanol cocoa drink (HFCD; 187 mg flavan-3-ols/100 ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-flavanol cocoa drink (LFCD; 14 mg/100 ml)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-flavanol cocoa drink (HFCD) with physical exercise
Number of subjects: 20
Study: 10737434

Group type: EXPERIMENTAL
Intervention: HIV-1 subtype B variants (GPGR, GWGR, GFGR, GPGS)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Neutralization by autologous sera
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Peptide ELISA seroreactivity
Number of subjects: 35
Study: 9285502

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of alpha-lipoic acid (ALA) 1,200 mg
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of alpha-lipoic acid (ALA) 600 mg
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Hamburg Pain Adjective List (HPAL) total scale with ALA 1,200 mg
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Hamburg Pain Adjective List (HPAL) total scale with ALA 600 mg
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Daily oral dose of alpha-lipoic acid (ALA) 800 mg
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 328
Study: 8099380

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Blood transfusion acquisition
Number of subjects: 47
Study: 3522558

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2573761

Group type: EXPERIMENTAL
Intervention: Sodium intake of 100 mmol per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sodium intake of 50 mmol per day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sodium intake of 200 mmol per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salt restriction for a further year
Number of subjects: 20
Study: 30203031

Group type: EXPERIMENTAL
Intervention: Brand-name label (n = 51)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Generic label (n = 50)
Number of subjects: 101
Study: 28376409

Group type: EXPERIMENTAL
Intervention: Mem‐ECT
Number of subjects: 59

Group type: COMPARATOR
Intervention: Active control (nonspecific mental stimulation)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 59
Study: 24585072

Group type: EXPERIMENTAL
Intervention: Promoting Sibling Bonds (PSB) intervention (n=13)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Comparison group (n=9)
Number of subjects: 22
Study: 23347721

Group type: EXPERIMENTAL
Intervention: Nebulized naloxone (2 mg in 3 mL normal saline)
Number of subjects: 73
Study: 21309842

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.2 mg
Number of subjects: 658

Group type: COMPARATOR
Intervention: Sitagliptin 100 mg
Number of subjects: 658
Study: 19424051

Group type: EXPERIMENTAL
Intervention: ZDV/3TC/LPV/r
Number of subjects: 50

Group type: COMPARATOR
Intervention: NVP/LPV/r
Number of subjects: 50
Study: 17074116

Group type: EXPERIMENTAL
Intervention: Moderate poisoning group
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Severe poisoning group
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Death group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Survival group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Mild poisoning group
Number of subjects: 97
Study: 15671203

Group type: EXPERIMENTAL
Intervention: CHF3381 (100, 200, and 400 mg twice daily for 2 weeks)
Number of subjects: 36
Study: 11595608

Group type: EXPERIMENTAL
Intervention: Digitalis
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 9386688

Group type: EXPERIMENTAL
Intervention: Antegrade blood cardioplegia (group 1)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Retrograde blood cardioplegia (group 2)
Number of subjects: 224
Study: 7525162

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 47
Study: 2956296

Group type: EXPERIMENTAL
Intervention: Isotretinoin (various dosage schedules)
Number of subjects: 72
Study: 29771211

Group type: EXPERIMENTAL
Intervention: Short-term anticoagulation (3-6 months)
Number of subjects: 1428

Group type: COMPARATOR
Intervention: Long-term anticoagulation (12 months)
Number of subjects: 1428
Study: 27956009

Group type: EXPERIMENTAL
Intervention: Maintenance varenicline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maintenance placebo
Number of subjects: 0
Study: 26226248

Group type: EXPERIMENTAL
Intervention: LUCM (long umbilical cord and milking)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (cord clamped at 5 cm and not milked)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: LUCM
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control
Number of subjects: 200
Study: 23706887

Group type: EXPERIMENTAL
Intervention: Building Our Solutions and Connections (BOSC) intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 61
Study: 21364739

Group type: EXPERIMENTAL
Intervention: Participants from Northern Ireland
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants from Serbia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants from Guatemala
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants from Peru
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalized additive mixed models
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall cross-cultural ratings
Number of subjects: 0
Study: 18191057

Group type: EXPERIMENTAL
Intervention: Therapeutic lifestyle modification (TLM) program for 4 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group received a booklet with basic education for metabolic syndrome
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: TLM intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both groups post-intervention
Number of subjects: 32
Study: 16818832

Group type: EXPERIMENTAL
Intervention: Peer counselor intervention (weekly for 6 weeks)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 108
Study: 14615626

Group type: COMPARATOR
Intervention: Healthy subjects (PET1 to PET2)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Aphasic patients (PET1 to PET2)
Number of subjects: 14
Study: 11081343

Group type: EXPERIMENTAL
Intervention: Hemodialysis therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Continuous ambulatory peritoneal dialysis
Number of subjects: 39
Study: 8869630

Group type: EXPERIMENTAL
Intervention: Teenage Mothers‐Grandmothers Program
Number of subjects: 65
Study: 1844997

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate, noncarbonated drink
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate, carbonated drink
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 10% carbohydrate, noncarbonated drink
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 10% carbohydrate, carbonated drink
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: All beverages (ad libitum drinking)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: All beverages (sweat rate, body weight loss, fluid replacement)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: All beverages (heart rate, rectal temperature, perceived exertion)
Number of subjects: 4
Study: 6190881

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Staphylococcus aureus nasal swabs from patients and operating staff
Number of subjects: 0
Study: 31122968

Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation (EMS) applied to the skeletal muscle of the entire lower extremity for 5 weeks, three times/week for 30-40 min during haemodialysis.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation (EMS)
Number of subjects: 20
Study: 30632329

Group type: EXPERIMENTAL
Intervention: 0.2% bio-adhesive chlorhexidine gel
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 180
Study: 26849799

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation at 400 mg per day
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 24436138

Group type: EXPERIMENTAL
Intervention: Fit4Life (tailored weight management intervention)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (generic weight management intervention)
Number of subjects: 38
Study: 22466947

Group type: EXPERIMENTAL
Intervention: Deep-needling (DN group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Superficial-needling (SN group)
Number of subjects: 65
Study: 20386121

Group type: EXPERIMENTAL
Intervention: Sprint condition (10 shots with sprints between attempts)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control condition (10 shots with 35-second rest)
Number of subjects: 11
Study: 18567081

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA) suppository
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 15778427

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir (800/200 mg qd or 400/100 mg bid)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: stavudine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: lamivudine
Number of subjects: 35
Study: 12028208

Group type: EXPERIMENTAL
Intervention: Sequential treatment with calcium alginate dressings (UrgoSorb) for 4 weeks followed by hydrocolloid dressings (Algoplaque) for 4 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Hydrocolloid dressings (DuodermE) for 8 weeks
Number of subjects: 110
Study: 10375362

Group type: EXPERIMENTAL
Intervention: Iron fortified preterm formula (0.9 mg/dl iron)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Fortified term formula (0.5 mg/dl iron)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Preterm formula (0.9 mg/dl iron) followed by term formula (0.5 mg/dl iron)
Number of subjects: 78
Study: 7770590

Group type: EXPERIMENTAL
Intervention: Self-report
Number of subjects: 0

Group type: COMPARATOR
Intervention: Structured interview
Number of subjects: 0

Group type: COMPARATOR
Intervention: Choice of procedure
Number of subjects: 0
Study: 2216187

Group type: EXPERIMENTAL
Intervention: 1 g cefazolin administered intramuscularly
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: 1 g cefazolin administered intravenously
Number of subjects: 772
Study: 319541

Group type: EXPERIMENTAL
Intervention: Metoprolol 120 mg/d
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Metoprolol 120 mg/d and 210 mg/d pooled results
Number of subjects: 93

Group type: COMPARATOR
Intervention: Propranolol 240 mg/d
Number of subjects: 93

Group type: COMPARATOR
Intervention: Propranolol 360 mg/d
Number of subjects: 93
Study: 31270036

Group type: EXPERIMENTAL
Intervention: EuroCTO (CASTLE) score
Number of subjects: 660

Group type: COMPARATOR
Intervention: J‐CTO score
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: EuroCTO (CASTLE) score for complex procedures (J‐CTO ≥3 or EuroCTO [CASTLE] ≥4)
Number of subjects: 660

Group type: COMPARATOR
Intervention: J‐CTO score for complex procedures (J‐CTO ≥3 or EuroCTO [CASTLE] ≥4)
Number of subjects: 660
Study: 31367728

Group type: EXPERIMENTAL
Intervention: Frail subjects
Number of subjects: 26

Group type: COMPARATOR
Intervention: Pre-frail subjects
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Total SPPB
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Balance SPPB sub-score
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: MNA score
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Hip flexor strength
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Walking time
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rising chair sub-score
Number of subjects: 26
Study: 29046265

Group type: EXPERIMENTAL
Intervention: Supported Web‐centered training
Number of subjects: 156

Group type: COMPARATOR
Intervention: Independent Web‐centered training
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Both training groups
Number of subjects: 156
Study: 24660151

Group type: EXPERIMENTAL
Intervention: Oral dextrose 10% given at 3 and 6 hours prior to the operation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no dextrose intervention)
Number of subjects: 120
Study: 24343071

Group type: EXPERIMENTAL
Intervention: Premedication with 40 mg parecoxib sodium and infiltration of 0.5% ropivacaine (20 mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (2 mL) intravenously before anesthesia induction and infiltration of 0.5% ropivacaine (20 mL)
Number of subjects: 60
Study: 20610322

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 340

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 340
Study: 18840791

Group type: EXPERIMENTAL
Intervention: Neptune Pad (n = 100)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Conventional manual compression (n = 101)
Number of subjects: 201
Study: 17086053

Group type: EXPERIMENTAL
Intervention: Carraguard vaginal gel
Number of subjects: 55